Details for Patent: 10,391,160
✉ Email this page to a colleague
Which drugs does patent 10,391,160 protect, and when does it expire?
Patent 10,391,160 protects TECFIDERA and is included in one NDA.
This patent has twelve patent family members in six countries.
Summary for Patent: 10,391,160
| Title: | Dimethyl fumarate and vaccination regimens |
| Abstract: | Provided herein is a method of treating or preventing a disease or disorder (e.g., MS) in a subject in need thereof, comprising (a) administering to the subject a first dose of a pharmaceutical composition comprising a fumarate agent (e.g., DMF) for a first dosing period; (b) administering a vaccine; and (c) administering to the subject a second dose of the pharmaceutical composition for a second dosing period. |
| Inventor(s): | Viglietta; Vissia (Boston, MA) |
| Assignee: | Biogen MA Inc. (Cambridge, MA) |
| Application Number: | 15/125,612 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 10,391,160
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biogen Inc | TECFIDERA | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 204063-001 | Mar 27, 2013 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | METHOD OF TREATING RELAPSING FORMS OF MULTIPLE SCLEROSIS BEFORE AND AFTER ADMINISTERING AN INACTIVE VACCINE | ⤷ Sign Up | |||
| Biogen Inc | TECFIDERA | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 204063-002 | Mar 27, 2013 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | METHOD OF TREATING RELAPSING FORMS OF MULTIPLE SCLEROSIS BEFORE AND AFTER ADMINISTERING AN INACTIVE VACCINE | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,391,160
| PCT Information | |||
| PCT Filed | March 13, 2015 | PCT Application Number: | PCT/US2015/020470 |
| PCT Publication Date: | September 17, 2015 | PCT Publication Number: | WO2015/138917 |
International Family Members for US Patent 10,391,160
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2016244325 | ⤷ Sign Up | |||
| Australia | 2018229422 | ⤷ Sign Up | |||
| Australia | 2020213345 | ⤷ Sign Up | |||
| Australia | 2022221548 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
